BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2705745)

  • 1. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
    Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and immunological heterogeneity of human ovarian neoplasms.
    Harłozińska A; Rabczyński J; Bar JK; Richter R
    Arch Immunol Ther Exp (Warsz); 1991; 39(4):419-29. PubMed ID: 1821619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms.
    Harłozińska A; Bar JK; Cisło M; Richter R; Rabczyński J
    Anal Cell Pathol; 1992 Jan; 4(1):1-12. PubMed ID: 1370907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma.
    Harlozinska A; Bar JK; Richter R; Cislo M
    Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Density distribution, cytomorphologic features and immunologic characteristics of ovarian and endometrial clear cell carcinomas.
    Harłozińska A; Rabczyński J; Bar JK; Richter R
    Acta Cytol; 1990; 34(5):657-63. PubMed ID: 2220244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated antigens in female genital tract cancers.
    Harlozinska A; Kula J; Stepinska B; Jelen M; Richter R
    Tumori; 1984 Jun; 70(3):281-9. PubMed ID: 6204430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen in human ovarian neoplasms.
    Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
    Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T; Maruo T; Iwasaki M; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of polyclonal and two monoclonal antibodies with cell subsets isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Bast RC; Richter R; Cisło M
    Tumori; 1990 Oct; 76(5):505-10. PubMed ID: 1701581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
    Shi ZL
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
    van Nagell JR; Pletsch QA; Goldenberg DM
    Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro.
    Pattillo RA; Story MT; Ruckert AC
    Cancer Res; 1979 Apr; 39(4):1185-92. PubMed ID: 421202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CEA and related antigens as possible new tumor markers].
    Matsuoka Y
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1754-63. PubMed ID: 6688338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic heterogeneity of human lung cancers.
    Harłozińska A; Richter R; Albert Z; Zawadzka H
    J Natl Cancer Inst; 1983 Mar; 70(3):427-33. PubMed ID: 6300497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated antigen for cystadenocarcinomas of the ovary.
    Bhattacharya M; Barlow JJ
    Natl Cancer Inst Monogr; 1975 Oct; 42():25-32. PubMed ID: 825781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.